![CapNostics logo](https://facit.ca/wp-content/uploads/2021/11/CapNostics.png)
Capnostics (Acquired by PAVmed)
www.businesswire.com
Innovation Type:
Medical Technologies
Cancer Type:
Other
Funding Stage:
Proof of Concept
Fund:
Prospects
CellMate product for esophageal cell sampling for early detection in patients at high risk of esophageal adenocarcinoma